Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Conditions › Scabies

Scabies

0 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Scabies

9 trials tracked for Scabies: 7 in phase 3 or 4 and 3 with published results. The most-cited published study has 71 citations.

9Trials tracked
7Phase 3 & 4
0Recruiting
3With published results
Phase distribution
Phase 4 2 Phase 3 5 Phase 2 2
  1. Phase 4 Azithromycin - Ivermectin Mass Drug Administration for Skin Disease Completed · 71 cited
  2. Phase 3 Impact of Community Scabies Treatment on Head Lice Prevalence in the Solomon Islands Completed · 25 cited
  3. Phase 4 Comparing the Effectiveness of Individual vs. Household Treatment for Scabies in Lambaréné, Gabon Completed · 14 cited
  4. Phase 3 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Completed
  5. Phase 3 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Completed
  6. Phase 3 Multiple-Site Study to Evaluate the Therapeutic Equivalence of Permethrin Cream, 5% in the Treatment of Scabies Completed
Show 3 more trials
  1. Phase 3 Bio-equivalence Study Comparing Permethrin Cream, 5% With Elimite in Patients With Active Scabies. Completed
  2. Phase 2 A Dose Ranging Vehicle Controlled Study to Determine the Safety and Efficacy of Permethrin Foam, 5% and Permethrin Foam, 4% for the Treatment of Scabies Completed
  3. Phase 2 Dose-finding Study of Moxidectin for Treatment of Scabies Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Scabies: what the trials found

Several pharmacological interventions are established for the treatment of scabies, including oral ivermectin [1, 3], topical applications such as benzyl benzoate 25% lotion 2, and various topical formulations including permethrin cream 5% [4, 5] and spinosad topical suspension 0.9% [6, 7].

Clinical data for ivermectin include evaluations of secondary complications; specifically, a large-scale study reported impetigo prevalence at 12 months and Group A Streptococcus presence following treatment 1.

Recent results — preliminary, needs further review

  • Moxidectin oral product is currently under investigation but not yet corroborated as an established treatment 8.
  • Permethrin foam 4% was evaluated in a Phase 2 trial; however, results for 'treatment success' after a single application did not show statistically significant differences between groups (p=0.6084), and re-treatment at day 14 also showed no statistically significant difference in success rates (p=0.6937) 9.

For the clinician treating this condition

  • Multiple treatment modalities are established for scabies, including oral ivermectin, topical benzyl benzoate, permethrin cream, and spinosad suspension.
  • Ivermectin has been evaluated in large-scale studies regarding its impact on secondary infections like impetigo and Group A Streptococcus 1.

AI synthesis of 4 cited trials, updated Jul 20, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
No published articles yet for this condition. Check back soon.